β1-adrenergic regulation of rapid component of delayed rectifier K+ currents in guinea-pig cardiac myocytes. 2014

Sen Wang, and Di Xu, and Ting-Ting Wu, and Yan Guo, and Yan-Hong Chen, and Jian-Gang Zou
Department of Geriatrics, First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu 210029, P.R. China.

Human ether-à-go-go-related gene (hERG) potassium channels conduct the rapid component of the delayed rectifier potassium current (IKr), which is crucial for repolarization of cardiac action potential. Patients with hERG‑associated long QT syndrome usually develop tachyarrhythmias during physical and/or emotional stress, both known to stimulate adrenergic receptors. The present study aimed to investigate a putative functional link between β1-adrenergic stimulation and IKr in guinea-pig left ventricular myocytes and to analyze how IKr is regulated following activation of the β1-adrenergic signaling pathway. The IKr current was measured using a whole-cell patch-clamp technique. A selective β1-adrenergic receptor agonist, xamoterol, at concentrations of 0.01-100 µM decreased IKr in a concentration-dependent manner. The 10 µM xamoterol-induced inhibition of IKr was attenuated by the protein kinase A (PKA) inhibitor KT5720, the protein kinase C (PKC) inhibitor chelerythrine, and the phospholipase (PLC) inhibitor U73122, indicating involvement of PKA, PKC and PLC in β1-adrenergic inhibition of IKr. The results of the present study indicate an association between IKr and the β1-adrenergic receptor in arrhythmogenesis, involving the activation of PKA, PKC and PLC.

UI MeSH Term Description Entries
D008297 Male Males
D010726 Phosphodiesterase Inhibitors Compounds which inhibit or antagonize the biosynthesis or actions of phosphodiesterases. Phosphodiesterase Antagonists,Phosphodiesterase Inhibitor,Phosphoric Diester Hydrolase Inhibitors,Antiphosphodiesterases,Inhibitor, Phosphodiesterase
D011760 Pyrrolidinones A group of compounds that are derivatives of oxo-pyrrolidines. A member of this group is 2-oxo pyrrolidine, which is an intermediate in the manufacture of polyvinylpyrrolidone. (From Merck Index, 11th ed) Pyrrolidinone,Pyrrolidone,Pyrrolidones
D004963 Estrenes Unsaturated derivatives of the ESTRANES with methyl groups at carbon-13, with no carbon at carbon-10, and with no more than one carbon at carbon-17. They must contain one or more double bonds. 19-Norandrostenes,19 Norandrostenes
D006168 Guinea Pigs A common name used for the genus Cavia. The most common species is Cavia porcellus which is the domesticated guinea pig used for pets and biomedical research. Cavia,Cavia porcellus,Guinea Pig,Pig, Guinea,Pigs, Guinea
D000200 Action Potentials Abrupt changes in the membrane potential that sweep along the CELL MEMBRANE of excitable cells in response to excitation stimuli. Spike Potentials,Nerve Impulses,Action Potential,Impulse, Nerve,Impulses, Nerve,Nerve Impulse,Potential, Action,Potential, Spike,Potentials, Action,Potentials, Spike,Spike Potential
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D017307 Xamoterol A phenoxypropanolamine derivative that is a selective beta-1-adrenergic agonist. Carwin,Corwin,ICI-118587,Xamoterol Fumarate,Xamoterol Hemifumarate,Xamoterol Maleate (2:1),Xamoterol Monohydrobromide,Xamoterol Monohydrochloride,Xamoterol, (S)-Isomer,Xamtol,Fumarate, Xamoterol,Hemifumarate, Xamoterol,ICI 118587,ICI118587,Monohydrobromide, Xamoterol,Monohydrochloride, Xamoterol
D051668 Delayed Rectifier Potassium Channels A group of slow opening and closing voltage-gated potassium channels. Because of their delayed activation kinetics they play an important role in controlling ACTION POTENTIAL duration. Delayed Rectifying Potassium Channels
D058665 Adrenergic beta-1 Receptor Agonists Compounds that bind to and activate ADRENERGIC BETA-1 RECEPTORS. Adrenergic beta-1 Agonists,Adrenergic beta-1 Receptor Agonist,Adrenergic beta1-Agonists,Adrenergic beta 1 Agonists,Adrenergic beta 1 Receptor Agonist,Adrenergic beta 1 Receptor Agonists,Adrenergic beta1 Agonists,Agonists, Adrenergic beta-1,beta-1 Agonists, Adrenergic,beta1-Agonists, Adrenergic

Related Publications

Sen Wang, and Di Xu, and Ting-Ting Wu, and Yan Guo, and Yan-Hong Chen, and Jian-Gang Zou
September 2019, Cellular and molecular biology (Noisy-le-Grand, France),
Sen Wang, and Di Xu, and Ting-Ting Wu, and Yan Guo, and Yan-Hong Chen, and Jian-Gang Zou
April 2000, The Journal of pharmacy and pharmacology,
Sen Wang, and Di Xu, and Ting-Ting Wu, and Yan Guo, and Yan-Hong Chen, and Jian-Gang Zou
November 1994, Circulation research,
Sen Wang, and Di Xu, and Ting-Ting Wu, and Yan Guo, and Yan-Hong Chen, and Jian-Gang Zou
July 1999, Zhongguo yao li xue bao = Acta pharmacologica Sinica,
Sen Wang, and Di Xu, and Ting-Ting Wu, and Yan Guo, and Yan-Hong Chen, and Jian-Gang Zou
July 2001, Yao xue xue bao = Acta pharmaceutica Sinica,
Sen Wang, and Di Xu, and Ting-Ting Wu, and Yan Guo, and Yan-Hong Chen, and Jian-Gang Zou
September 2003, Clinical and experimental pharmacology & physiology,
Sen Wang, and Di Xu, and Ting-Ting Wu, and Yan Guo, and Yan-Hong Chen, and Jian-Gang Zou
February 1994, European journal of pharmacology,
Sen Wang, and Di Xu, and Ting-Ting Wu, and Yan Guo, and Yan-Hong Chen, and Jian-Gang Zou
June 2006, The Journal of physiology,
Sen Wang, and Di Xu, and Ting-Ting Wu, and Yan Guo, and Yan-Hong Chen, and Jian-Gang Zou
December 1999, British journal of pharmacology,
Sen Wang, and Di Xu, and Ting-Ting Wu, and Yan Guo, and Yan-Hong Chen, and Jian-Gang Zou
February 2004, The Journal of physiology,
Copied contents to your clipboard!